Rising Biopharma Investments in Emerging Economies
Emerging economies are becoming hotbeds for biopharma investments, and this is impacting the Host Cell Protein Testing Market. Governments in regions like Southeast Asia, the Middle East, and Latin America are offering tax incentives and building biotech parks to attract global players.With more facilities being set up, there is a corresponding rise in demand for advanced HCP testing services to comply with international regulations.
3 Views